Rotator Cuff Tears
Conditions
Brief summary
The perspective, randomized controlled trial is to investigate and evaluate the effect of Tizanidine on the function and pain of patients with rotator cuff tear after shoulder arthroscopy;
Interventions
DRUGCelecoxib+Buprenorphine Transdermal Patch
NSAIDs+narcotic analgesics
DRUGCelecoxib+Buprenorphine Transdermal Patch+Tizanidine
NSAIDs+narcotic analgesics+Skeletal Muscle Relaxant
Sponsors
Second Affiliated Hospital, School of Medicine, Zhejiang University
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)
Eligibility
Sex/Gender
ALL
Age
20 Years to 70 Years
Healthy volunteers
No
Inclusion criteria
1 Patients who were diagnosed as supraspinatus tendon and infraspinatus tendon tear and underwent shoulder arthroscopic surgery in the Second Affiliated Hospital of Zhejiang University; 2 Age 20\ 70 years old; 3 Those with a long medical history, and symptoms such as shoulder joint pain and weakness in a short period of time are obviously aggravated; 4. After 3 months of medication and physical therapy, the symptoms and functions have not improved significantly; 5 Volunteer to participate in this study, and the person and his/her family members have given informed consent to the content of this study and signed the consent form
Exclusion criteria
1. Patients with simple frozen shoulder; 2. Patients with shoulder joint tuberculosis, gout, tumor, rheumatoid disease or infectious disease; 3. There are other joint pain factors before operation; 4 Patients with subscapularis tendon tear, long head tendinopathy requiring surgical treatment, and severe shoulder synovitis were found during the operation; 5 Patients with upper limb nerve injury, shoulder fracture, bone defect or severe osteoporosis; 6. Patients with serious organ or hematopoietic system and other primary diseases; 7. Those who are allergic to the drugs used in this study; 8 Women who are breast-feeding, pregnant or preparing to become pregnant; 9 Patients with language and communication disorders, mental history, cognitive dysfunction, etc. who cannot cooperate with the completion of nursing intervention and research, and cannot complete the questionnaire required for this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pittsburgh sleep quality index；PSQI | From Week 0 (baseline) to Week24 |
Secondary
| Measure | Time frame |
|---|---|
| American Shoulder and Elbow Surgeons Score; ASES | From Week 0 (baseline) to Week24 |
| UCLA score; UCLA | From Week 0 (baseline) to Week24 |
| Visual Analogu Scale; VAS | From Week 0 (baseline) to Week24 |
| Oxford Shoulder Score; OSS | From Week 0 (baseline) to Week24 |
Contacts
Primary ContactGuang Yang
Outcome results
None listed